First Smoke of the Day LogoJournal
News

Nebraska Sets a Steep Price Tag on Medical Cannabis Licenses

  • Collin Johnson, Head Editor of First Smoke of the DayCollin Johnson
  • July 21, 2026
Nebraska Sets a Steep Price Tag on Medical Cannabis Licenses

Nebraska just showed its hand on what it will cost to run a medical cannabis business in the state. The numbers are high enough to change who can actually afford to play.

The Nebraska Medical Cannabis Commission put out its first draft of updated rules this week. This plan attaches a fee to almost every step of getting licensed. Up front, you pay a $5,000 application fee. But the real cost lives in the fees that come back year after year. There's a license and renewal fee that changes based on your business type. There's a $1,500 fee just to move locations. And there's a $13,000 charge to plug into the state's seed-to-sale tracking system. Want to license a new product? That's another $250, plus $100 to renew it.

One thing changed in this draft. The commission dropped the standalone transporter license. Now product manufacturers can just add a transporter certification to what they already run. They had hinted this was coming.

What the licenses cost

Here's how the proposed fees break down by license type:

  • Cultivators pay $20,000 for a new license and $23,500 to renew each year.
  • Transporter certification runs $10,000 as an add-on.
  • Product manufacturers pay $20,000 for a new license. Renewals are $23,500 without a transporter certification, or $28,500 with one.
  • Dispensaries pay $15,000 for a new license and $18,000 to renew each year.

Now add the $13,000 seed-to-sale fee on top of every renewal. Do the math and most licensees are paying somewhere north of $30,000 a year. For some, it climbs past $40,000. That's every single year, with no end in sight.

A market built to stay small

The rules keep the market tight on purpose. The state allows just four cultivators, four product manufacturers, and twelve dispensaries total. They get spread out by judicial district. In plain terms, that means one dispensary each for Nebraska's biggest county clusters: Douglas, Lancaster, the Sarpy and Cass area, and the Buffalo and Hall area. All four cultivator licenses are already spoken for. Only one grower has the green light to actually start growing.

The commission opened manufacturer applications after its June meeting. So far, at least two businesses have applied. Officials pushed the deadline to August 17 to give more of them a shot. When will the first manufacturer licenses get approved? Nobody's saying for sure. Realistically, it won't happen before September, since the commission only meets once a month. And there's still no timeline at all for the first dispensaries.

Patients and advocates are running out of patience

A lot of the public comment came from the same people who got this on the ballot in the first place. They led the voter campaign in 2024 that created the commission. Their message was simple. Move faster.

Crista Eggers runs Nebraskans for Medical Marijuana. She made it personal, describing what it feels like to spend a decade fighting for access while wondering if her own son will ever get help. Troy Burgess has worked in medical cannabis for six years in states like Oklahoma, and he's one of the two current manufacturer applicants. He didn't soften it. He warned that "plants in the ground" don't mean patients will ever get real medicine. Both of them told commissioners to start working with lawmakers now, before the January session, so they can fix the gaps around testing, patient privacy, and legal protections for providers.

How the commission sees it

Interim chair Lorelle Mueting took a calmer view. She framed the fees as proof of the groundwork the agency laid in its first year. "Building a new regulatory agency is much like constructing a house," she said. The commission recently hired its first real staff, a program manager and an in-house attorney, and it's still looking for an executive director. Mueting says the fees are what keep that hiring going. She also said the commission set them after looking at other states with similar populations and rules.

Getting here took sign-off from Nebraska's top two Republicans. Attorney General Mike Hilgers and Gov. Jim Pillen approved the underlying regulations earlier this month. That folded them into the state administrative code and opened the door to fees. The Legislature gave the commission the power to charge those fees this spring, and it funded the agency too. Lawmakers didn't manage to do that in 2025. One question still hangs over everything. Pillen recently told state agencies to cut spending and get approval before hiring, and nobody knows yet how that hits the commission's budget.

The fee package passed 3 to 0, pending one last review by the commission's new attorney. The next meeting is set for 1 p.m. on August 17.

This article is based on reporting by Zach Wendling for the Nebraska Examiner, published via Marijuana Moment. Read the original coverage at nebraskaexaminer.com.

Our Take

Let's not dress this up. Nebraska built a program that looks less like patient access and more like a toll booth. Voters said yes to medical cannabis back in 2024. Here we are in mid-2026 with nothing on shelves, no dispensary timeline, and a fee structure that quietly locks out anyone who isn't already sitting on serious money. Think about the math. A $13,000 tracking fee at every renewal, stacked on top of $20,000 to $28,000 in license costs, means you're paying $30,000 to $40,000 a year just to stay open. And that's before you sell a single gram. Twelve dispensaries for the whole state isn't a market. It's a handful of protected players, and they'll price their product like it.

The commission calls this "building a house." Patients experience it as slow-walking, and every month of delay has a real cost. It gets measured in families who were promised relief and are still waiting. For the rest of the industry, Nebraska is a lesson in how a voter mandate gets absorbed, capped, and turned into revenue until it barely looks like what people voted for. Yes, there's real money to be made here for whoever can afford the buy-in. But let's be honest about who this rollout was built for, and it wasn't patients.


Stay in the Room

Membership gets you full episodes, behind-the-scenes, and more. Start with a free trial.

Start Your Free Trial